Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $481,373 |
Sells | 22 | $13,157,642 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
25 Oct 2024 19:55 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 24 Oct 2024 | Sale | 141,360 | 4.3772 | 618,761 | D |
25 Oct 2024 19:55 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 25 Oct 2024 | Sale | 3,200 | 4.375 | 14,000 | D |
25 Oct 2024 19:54 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 23 Oct 2024 | Sale | 16 | 4.375 | 70 | D |
25 Oct 2024 19:54 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 24 Oct 2024 | Sale | 140,000 | 4.3773 | 612,822 | D |
25 Oct 2024 19:54 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 25 Oct 2024 | Sale | 4,800 | 4.3758 | 21,004 | D |
22 Oct 2024 20:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 18 Oct 2024 | Sale | 245,784 | 4.3809 | 1,076,755 | D |
22 Oct 2024 20:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 21 Oct 2024 | Sale | 110,456 | 4.3796 | 483,753 | D |
22 Oct 2024 20:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 22 Oct 2024 | Sale | 157,912 | 4.3868 | 692,728 | D |
22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 18 Oct 2024 | Sale | 249,728 | 4.3807 | 1,093,983 | D |
22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 21 Oct 2024 | Sale | 116,696 | 4.3796 | 511,082 | D |
22 Oct 2024 20:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 22 Oct 2024 | Sale | 159,344 | 4.3849 | 698,708 | D |
13 Sep 2024 16:15 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 11 Sep 2024 | Sale | 600,000 | 3.7572 | 2,254,320 | D |
13 Sep 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 11 Sep 2024 | Sale | 600,000 | 3.7568 | 2,254,080 | D |
14 Aug 2024 16:16 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 13 Aug 2024 | Sale | 390,184 | 3.201 | 1,248,979 | D |
14 Aug 2024 16:16 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 13 Aug 2024 | Sale | 8,216 | 3.25 | 26,702 | D |
14 Aug 2024 16:16 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 12 Aug 2024 | Sale | 1,600 | 3.13 | 5,008 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 13 Aug 2024 | Sale | 3,736 | 3.25 | 12,142 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 13 Aug 2024 | Sale | 394,664 | 3.2012 | 1,263,398 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 12 Aug 2024 | Sale | 1,600 | 3.13 | 5,008 | D |
14 Aug 2024 16:15 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 12 Aug 2024 | Purchase | 36,000 | 2.87 | 103,320 | D |
03 May 2024 19:21 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 May 2024 | Sale | 36,248 | 1.9596 | 71,032 | D |
05 Feb 2024 18:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 05 Feb 2024 | Sale | 36,248 | 2.2209 | 80,503 | D |
22 Nov 2023 17:09 | VRNA | Verona Pharma plc | EDWARDS MARTIN | Director | 20 Nov 2023 | Purchase | 33,736 | 1.837 | 61,973 | D |
08 Nov 2023 16:15 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 06 Nov 2023 | Purchase | 160,000 | 1.9755 | 316,080 | D |
03 Nov 2023 20:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Nov 2023 | Sale | 58,752 | 1.92 | 112,804 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)